Table 1.
Baseline characteristics of patients in three groups.
| NV group (n = 31) | OV group (n = 21) | TV group (n = 60) | p value | |
|---|---|---|---|---|
| Gender (M) | 13 (42) | 15 (71) | 37 (62) | 0.08 |
| Age (years) | 36.9 ± 13.8 | 22.5 ± 13.9 | 33.7 ± 13.7 | 0.001 |
| BMI (Kg/ m2) | 22.7 ± 3.6 | 22.0 ± 5.8 | 23.2 ± 3.6 | 0.53 |
| Comorbidities | 0.32 | |||
| Hypertension | 2 (7) | 0 (0) | 1 (2) | |
| Cirrhosis | 2 (7) | 0 (0) | 1 (2) | |
| Operation history | 1 (3) | 1 (5) | 1 (2) | |
| COPD | 1 (3) | 0 (0) | 1 (2) | |
| Type 2 diabetes | 0 (0) | 2 (10) | 1 (2) | |
| Any symptoms | 31 (100) | 16 (76) | 33 (55) | <0.05 |
| Stuffy nose/snot | 1 (3) | 1 (5) | 1 (2) | 0.74 |
| Sore throat | 4 (13) | 1 (5) | 3 (5) | 0.35 |
| Cough | 14 (45) | 7 (33) | 20 (33) | 0.52 |
| Sputum production | 8 (26) | 4 (19) | 5 (8) | 0.08 |
| Dyspnea | 1 (3) | 0 (0) | 1 (2) | 0.69 |
| Intestinal symptom | 3 (10) | 0 (0) | 0 (0) | 0.02 |
| Anosmia/dysgeusia | 3 (10) | 3 (14) | 2 (3) | 0.20 |
| Fatigue | 0 (0) | 0 (0) | 1 (2) | 0.65 |
Data are presented as n (%) or mean ± standard deviation. NV: non-vaccines; OV: one-vacine; TV: two-vaccine; M: male; kg: kilogram; BMI: body mass index; COPD: chronic obstructive pulmonary disease. p value, comparison among groups.